Biochemistry of the Growth Hormone-Releasing Peptides, Secretagogues and Ghrelin

  • Cyril Y. Bowers
  • Jaw-Kang Chang
  • Shaoxing Wu
  • Klaus D. Linse
  • David L. Hurley
  • Johannes D. Veldhuis


A general chronology of growth hormone-releasing peptide (GHRP) and ghrelin and their shared receptor is shown in Table 1 [1] [3]. The discovery of the natural hormone ghrelin appears to be the exciting beginning of a new unusual hormone system. Initially, in 1980, GH-releasing activity of the unnatural GHRPs was thought to represent the activit y of the as-yet unidentified natural hypophysiotrophic hormone GH-releasing hormone (GHRH). However, in 1982, GHRH was isolated from a pancreatic tumour and the hypothalamus and chemically identified as 44 and 40 amino acid linear peptides. Although the GH-releasing activity of GHRPs and GHRH are similar, it is also apparent that they are definitely chemically and functionally different because of the uniqueness of the action of GHRP on GH secretion in vitro as well as in vivo in a variety of animal species. In 1984, it was postulated that GHRP reflected the activity of another new hypothalamic hormone involved in the increased secretion of GH and thus was in need of isolation.


Ghrelin Level Growth Hormone Secretagogue Growth Hormone Secretagogue Receptor Ghrelin Receptor Human Ghrelin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bowers CY (1999) GH releasing peptides (GHRPs). In: Kostyo J, Goodman H (eds) Handbook of Physiology. Oxford University Press, New York, vol 7, pp 267–297Google Scholar
  2. 2.
    Bowers CY (1998) Growth hormone releasing peptide (GHRP). Cell Mol Life Sci 54:1316–1329PubMedCrossRefGoogle Scholar
  3. 3.
    Veldhuis JD, Bowers CY (2003) Sex-steroid modulation of growth hormone (GH) secretory control. Endocrine 22:25–39PubMedCrossRefGoogle Scholar
  4. 4.
    Howard AD, Feighner SD, Cully DF et al (1966) A receptor in pituitary and hypothalamus and functions in growth hormone release. Science 273:974–977CrossRefGoogle Scholar
  5. 5.
    Kojima M, Hosada H, Date Y et al (1999) Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 402:656–660PubMedCrossRefGoogle Scholar
  6. 6.
    Bowers CY (2001) Unnatural growth hormonereleasing peptide begets natural ghrelin. J Clin Endocrinol Metab 86:1464–1469PubMedCrossRefGoogle Scholar
  7. 7.
    Bowers CY, Granda-Ayala R, Mohan S et al (2004) Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-1), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. J Clin Endocrinol Metab 89:2290–2300PubMedCrossRefGoogle Scholar
  8. 8.
    Hataya Y, Akamizu T, Kazuhiko T et al (2001) A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86:4552–4555PubMedCrossRefGoogle Scholar
  9. 9.
    Kohno D, Gao H-Z, Muroya S et al (2004) Ghrelin directly interacts with neuropeptide Y-containing neurons in the rat arcuate nucleus. Diabetes 52:948–956CrossRefGoogle Scholar
  10. 10.
    Matsumoto M, Hosoda H, Kitajima Y et al (2001) Structure-activity relationship of ghrelin: Pharmacological study of ghrelin peptides. Biochem Biophys Res Commun 287:142–146PubMedCrossRefGoogle Scholar
  11. 11.
    Matsumoto M, Kitajima Y, Iwanami T et al (2001) Structural similarity of ghrelin derivatives to peptidyl growth hormone secretagogues. Biochem Biophys Res Commun 284:655–659PubMedCrossRefGoogle Scholar
  12. 12.
    Bednarek MA, Feighner SD, Pong SS et al (2000) Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor la. J Med Chem 43:4370–4376PubMedCrossRefGoogle Scholar
  13. 13.
    Thompson N, Gill DAS, Davies R et al (2004) Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type la growth hormone secretagogue receptor. Endocrinology 145:234–242PubMedCrossRefGoogle Scholar
  14. 14.
    Choi K, Roh SG, Hong YH et al (2003) The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144:754–759PubMedCrossRefGoogle Scholar
  15. 15.
    Cassoni P, Papotti M, Ghe C et al (2001) Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86:1738–1745PubMedCrossRefGoogle Scholar
  16. 16.
    Baldanzi G, Filigheddu N, Cutrupi S et al (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-Kinase/AKT. J Cell Biol 159:1029–1037PubMedCrossRefGoogle Scholar
  17. 17.
    Hosoda H, Kojima M, Mizushima T et al (2003) Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 278:64–70PubMedCrossRefGoogle Scholar
  18. 18.
    Gnanapavan S, Kola B, Bustin SA et al (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988–2991PubMedCrossRefGoogle Scholar
  19. 19.
    Tomassetto C, Karam SM, Ribieras S et al (2000) Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 119:395–405CrossRefGoogle Scholar
  20. 20.
    Inui A, Asakawa A, Bowers CY et al (2004) Appetite and growth—the emerging role of the stomach as an endocrine gland. FASEB J 18:439–456PubMedCrossRefGoogle Scholar
  21. 21.
    Lu S, Guan JL, Wang, QP et al (2002) Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 321:157–160PubMedCrossRefGoogle Scholar
  22. 22.
    Silva Elipe MV, Bednarek MA, Gao YD (2001) 1H NMR structural analysis of human ghrelin and its six truncated analogs. Biopolymers 59:489–501PubMedCrossRefGoogle Scholar
  23. 23.
    Feighner SD, Howard AD, Prendergast K et al (1998) Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and non-peptide secretagogues. Mol Endocrinol 12:137–145PubMedCrossRefGoogle Scholar
  24. 24.
    Holst B, Cygankiewicz A, Jensen TH et al (2003) High constitutive signalling of the ghrelin receptoridentification of a potent inverse agonist. Mol Endocrinol 17:2201–2210PubMedCrossRefGoogle Scholar
  25. 25.
    Kim M-S, Yoon C-Y, Park K-H et al (2003) Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport 14:1317–1320PubMedCrossRefGoogle Scholar
  26. 26.
    Bouret SG, Draper SJ, Simerly RB (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304:108–110PubMedCrossRefGoogle Scholar
  27. 27.
    Pinto S, Roseberry AG, Hongyan L et al (2004) Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304:110–115PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Cyril Y. Bowers
    • 1
  • Jaw-Kang Chang
    • 2
  • Shaoxing Wu
    • 3
  • Klaus D. Linse
    • 4
  • David L. Hurley
    • 5
  • Johannes D. Veldhuis
    • 6
  1. 1.Department of Medicine, Division of Endocrinology and MetabolismTulane University Health Sciences CenterNew OrleansUSA
  2. 2.Phoenix Pharmaceuticals Inc.BelmontUSA
  3. 3.NMR Research Center, Emory UniversityAtlantaUSA
  4. 4.Institute for Cellular and Molecular BiologyUniversity of TexasAustinUSA
  5. 5.Department of BiochemistryTulane University Health Sciences CenterNew OrleansUSA
  6. 6.Department of Internal Medicine, Division of Endocrinology and MetabolismMayo Medical and Graduate SchoolsRochesterUSA

Personalised recommendations